Avrobio Inc reported $129.5M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Akebia Therapeutics AKBA:US USD 435.89M 85.91M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Applied Genetic Technologies AGTC:US USD 57.33M 9.35M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Gilead Sciences GILD:US USD 62.56B 313M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Karyopharm Therapeutics KPTI:US USD 231.24M 25.24M
Macrogenics MGNX:US USD 195.35M 22.7M
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Takeda 4502:JP JPY 14.59T 523.42B